Tang Capital Management LLC Increases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Tang Capital Management LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 62.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,308 shares of the healthcare conglomerate’s stock after buying an additional 886 shares during the period. Tang Capital Management LLC’s holdings in UnitedHealth Group were worth $1,168,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in the stock. NewSquare Capital LLC purchased a new stake in UnitedHealth Group during the 4th quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group during the 4th quarter worth $26,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group during the 4th quarter worth $28,000. AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group during the 4th quarter worth $30,000. Finally, Aster Capital Management DIFC Ltd acquired a new position in UnitedHealth Group in the 4th quarter worth $30,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Kristen Gil acquired 3,700 shares of the firm’s stock in a transaction dated Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the acquisition, the director now directly owns 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO John F. Rex bought 17,175 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the purchase, the chief financial officer now owns 203,796 shares of the company’s stock, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock worth $31,607,768 over the last three months. Corporate insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on UNH shares. Mizuho cut their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a report on Friday. Oppenheimer cut their price objective on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating on the stock in a report on Wednesday. Truist Financial cut their price objective on shares of UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating on the stock in a report on Monday, April 21st. Morgan Stanley cut their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a research note on Wednesday. Finally, Barclays cut their target price on shares of UnitedHealth Group from $513.00 to $362.00 and set an “overweight” rating on the stock in a research note on Thursday. Six research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $486.00.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $291.24 on Friday. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a market cap of $264.20 billion, a PE ratio of 18.79, a P/E/G ratio of 1.37 and a beta of 0.56. The firm has a 50-day simple moving average of $470.82 and a 200 day simple moving average of $513.60.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the company posted $6.91 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 2.88%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.18%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.